SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hunter Biden’s Laptop (LAPTOP) is a memecoin referencing the eponymous Hunter Biden laptop sensation that’s been a fixture in global media news cycles for the past six years. LAPTOP is a fungible, freely transferable, non-yield-bearing ERC-20 token on Base. As a memecoin, LAPTOP has no utility, but incorporates two novel distribution mechanics designed to promote long-term community growth: a large community airdrop and an event-based supply mechanism.

Hunter Biden's Laptop

The $LAPTOP.X meme coin is experiencing extreme volatility and significant community backlash following a rapid, sharp decline in value shortly after its launch. Traders are labeling the event a "rug pull," with many expressing frustration over substantial financial losses and debating the legitimacy of politically themed cryptocurrency projects.

AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.

Astrazeneca plc

AstraZeneca PLC

AstraZeneca shares have been reacting to positive late-stage clinical trial results for its COPD drug, tozorakimab, which met primary endpoints and revived confidence in the company's respiratory pipeline.

Starbucks Corp. engages in the production, marketing, and retailing of specialty coffee. It operates through the following segments: North America, International, and Channel Development. The North America segment focuses on the United States and Canada. The International segment is involved in China, Japan, Asia Pacific, Europe, Middle East, Africa, Latin America, and Caribbean. The Channel Development segment includes roasted whole bean and ground coffees, Seattle’s Best Coffee, and Teavana-branded single-serve products. The company was founded by Jerry Baldwin and Howard D. Schultz on November 4, 1985, and is headquartered in Seattle, WA.

Starbucks Corp.

Starbucks Corp

Starbucks is trending as traders discuss the company's recent push into in-house AI tools to reduce reliance on third-party software, alongside broader debate over whether the brand's turnaround under its new CEO is sustainable. While some investors remain optimistic about traffic recovery, others express skepticism, pointing to increased competition from lower-cost rivals and broader consumer spending pressures.

Select Sector SPDR Trust (The) - State Street Health Care Select Sector SPDR ETF

Health Care Select Sector SPDR Fund

The Health Care Select Sector SPDR Fund (XLV) is currently trending as traders and analysts debate its role as a defensive rotation play amid broader market volatility. Much of the conversation centers on technical analysis, with market participants closely monitoring the ETF's price action against key support zones and institutional rotation into healthcare stocks as a hedge against tech-sector fluctuations.

What Is Tezos (XTZ)?   Tezos is a high-performing blockchain and open-source platform for assets and applications, with a strong focus on code security, on-chain governance, and decentralization. Tezos 2.0, the upcoming step in the evolution of Tezos, aims to improve scalability (via layer 2s), composability, and to implement support to mainstream programming languages (like Javascript, Typescript, Python, and many others).   Initially built with formal verification in mind, the Tezos protocol enables builders to avoid bugs when developing smart contracts, making it particularly suited to applications that require a high degree of security and certainty.   Tezos’ LPoS (Liquid Proof-of-Stake) consensus mechanism enables any stakeholder to take part, directly or by delegation, in the consensus process, and to be rewarded for securing the network. Rather uniquely, Tezos’ on-chain governance system also enables stakeholders to create and vote on protocol upgrade proposals. This pioneering system allows the protocol to self-amend and upgrade itself without leading to a split (or fork) in the blockchain, empowering the community without slowing down innovation.   First proposed in 2014 and launched in 2018, the Tezos Mainnet has a proven track record of running uninterrupted ever since, having earned a strong reputation for technical excellence and a supportive community.    Who Are the Founders of Tezos? Tezos was conceived by Arthur and Kathleen Breitman in a 2014 white paper under the pseudonym L.M. Goodman in a nod to Satoshi Nakamoto, referencing a journalist who had misidentified the creator of Bitcoin.   In a previous paper, the Breitmans had argued that Bitcoin's biggest shortcomings were the lack of a governance process that invited contributions from its community of users, cost and centralization issues raised by its proof-of-work system, the limited expressiveness of its programming language which didn’t allow for smart contracts, and security

Tezos

Tezos is experiencing significant volatility and downward pressure, with traders debating whether recent price action represents a buying opportunity or a continuing long-term downtrend. The conversation is dominated by intense disagreement between bearish participants predicting further declines and retail investors looking for entry points in anticipation of future market cycles.

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

BioNTech SE - ADR

BioNTech shares are experiencing significant volatility following a weak financial outlook and the announcement that its co-founders will step down by year-end to launch a new venture, despite the company's progress in its late-stage oncology pipeline.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics' shares fell in sympathy with the broader biotech sector following a failed Phase 3 trial for a competitor's myotonic dystrophy (DM1) drug. While investors expressed frustration over the market's reaction, others noted that the company's DMD franchise remains its core value driver and are looking toward upcoming clinical catalysts to clarify the company's long-term potential.

The Walt Disney Co. engages in the business of international family entertainment and media enterprise. It owns and operates television and radio production, distribution and broadcasting stations, direct-to-consumer services, amusement parks, and hotels. It operates through the following business segments: Disney Entertainment, ESPN, and Disney Parks, Experiences, and Products. The company was founded by Walter Elias Disney on October 16, 1923 and is headquartered in Burbank, CA.

Walt Disney Co (The)

Walt Disney Co

The stock is receiving attention following a strategic multi-year partnership with Kraft Heinz, which will integrate products into North American properties and leverage Disney characters for retail. Traders are also discussing the company's long-term performance, box office success from recent releases, and ongoing speculation regarding potential restructuring or divestments.

Ford Motor Co. engages in the manufacture, distribution, and sale of automobiles. It operates through the following segments: Ford Blue, Ford Model E, Ford Pro, Ford Credit, and Corporate Other. The Ford Blue, Ford Model E, and Ford Pro segment includes the sale of Ford and Lincoln vehicles, service parts, and accessories, together with the associated costs to develop, manufacture, distribute, and service the vehicles, parts, and accessories. The Ford Credit segment consists of the Ford Credit business on a consolidated basis, which is primarily vehicle-related financing and leasing activities. The Corporate Other segment refers to corporate governance expenses, past service pension and OPEB income and expense, interest income and gains and losses from cash, cash equivalents, and marketable securities, and foreign exchange derivatives gains, and losses associated with intercompany lending. The company was founded by Henry Ford on June 16, 1903 and is headquartered in Dearborn, MI.

Ford Motor Co.

Ford Motor Co

Ford is experiencing heightened volatility following the release of its latest vehicle sales figures, which traders are debating alongside potential tariff risks for U.S.-Canada automotive trade. Market sentiment remains divided, with some investors focusing on the company's long-term transformation and strategic EV investments, while others express frustration over inconsistent price action and management's handling of production and margins.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is experiencing significant volatility driven by the cancellation of Executive Chair Larry Ellison's pre-arranged stock-sale plan, which traders believe has effectively trapped short sellers and sparked anticipation of a potential squeeze. While some investors remain cautious about the company's high capital expenditures and negative free cash flow, the community is largely divided between bullish sentiment regarding the stock's long-term potential and skepticism from bears who view the recent price action as manipulative.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

The IWM is trending as traders focus on rising bond yields and potential Fed rate hike expectations, while debating if broader market strength is being masked by mega-cap stocks. Sentiment remains cautious with heavy discussion on macroeconomic headwinds, including volatility in oil prices and geopolitical tensions.

Second Time’s The Charm: FDA Clears Scholar Rock’s SMA Drug Ahead Of Deadline, SRRK Soars 15% After-Hours  

Equity

FDA approved Isembyld for patients age two and older who already take certain spinal muscular atrophy drugs. 


Wall Street Sounds Positive On BRZE Stock Despite Post-Earnings Decline – These Analysts See Buying Opportunity

Raymond James, UBS, and Canaccord raised their price targets on the stock, while Stifel and Stephens called the post-earnings weakness a buying opportunity.


PHAT Stock Falls 7% As Leerink Sees Little Near-Term Upside — CEO Plays Down Upcoming Rival 

Leerink said that VOQUEZNA competes in a “highly genericized” gastroesophageal reflux disease market against long-available proton pump inhibitors (PPI). 


Why Is EVMN Stock Down 13% After-Hours?

Evommune said on Tuesday that its mid-stage trial involving its experimental eczema pill EVO756 failed a mid-stage study. 


ALMS Stock Clocks Worst Day After 57% Drop — What Drove The Selloff?

The selloff followed topline results from the Phase 2b LUMUS trial of envudeucitinib in moderate-to-severe systemic lupus erythematosus, or SLE, a chronic autoimmune disease in which the body's immune system mistakenly attacks healthy tissues. 


CRSP Stock Slips 3% Despite ‘Encouraging’ CTX310 Data — Morgan Stanley Says Investor Focus Is Further Ahead

Morgan Stanley expects investor focus to shift to readouts from the next part of the same trial in patients with severe hypertriglyceridemia due in the back half of the year and other second-half readouts.


BHVN Stock On Track For Best Day In Over 2 Months After SK Biopharmaceuticals Licenses Epilepsy Drug: Retail Now Awaits Obesity Trial Readout   

Under the agreement, SK Biopharmaceuticals gets exclusive worldwide rights to Biohaven’s Kv7 platform and its lead once-daily pill, opakalim. 


SRRK Stock Gains After Company Drops Troubled Novo Nordisk-Owned Plant From FDA Filing  

The company said it has, in accordance with FDA guidance, removed Catalent Indiana—a fill-finish plant now owned by Novo Nordisk—from its U.S. biologics license application for apitegromab.


CRML Stock On Track For Best Day In About 4 Months — What’s Driving The Rally?

Critical Metals CEO said in a Bloomberg interview that its rare earth project in Greenland is still on schedule for first production in 2029.  


BULL Stock Eyes Highest Levels In 8 Months — Here's Why Rosenblatt Sees A 67% Upside Potential

According to TheFly, analysts at Rosenblatt maintained their ‘Buy’ rating on Webull and raised their price target to $15 from $13.


iShares Trust - iShares Russell 2000 Index Fund

Bearish Sentiment

President Trump has promised to issue a $5,000 "dividend" check to every adult American citizen if the Republican Party wins control of both the House and the Senate in the upcoming midterm elections, though the proposal would require congressional approval and follows his earlier $2,000 tariff-dividend plan, which stalled after the Supreme Court struck down much of his tariff authority. Do you think the $5,000 dividend check actually happens? Vote and explain your reasoning in the comments.

Trump has pledged a $5,000 &quot;dividend&quot; check to every adult American citizen if Republicans win control of both the House and Senate in the midterms. Do you think it actually happens?

Stocktwits

Trump has pledged a $5,000 "dividend" check to every adult American citizen if Republicans win control of both the House and Senate in the midterms. Do you think it actually happens?

Stocktwits Polls

iShares Russell 2000 ETF

Markets are pricing in a surging 90% probability of a September rate hike amid stubborn inflation data and rising bond yields.

Crude oil climbing toward $100+ is fueling inflation fears and creating a volatile backdrop for equities.

Small-cap indexes are facing extreme selling pressure as high borrowing costs and rising treasury yields disproportionately impact their margins.

Investors are shifting focus away from broad index bets, rotating into specific high-quality energy and power infrastructure names.

Feed

News

Sentiment

Fundamentals

Info

IWM News